BDBM492884 N-((5-chloro-1H- indazol-3-yl)methyl)-3- (1-(4-((2-oxopyridin- 1(2H)- yl)methyl)phenyl)vinyl) benzamide::US10981893, Example 13

SMILES Clc1ccc2[nH]nc(CNC(=O)c3cncc(c3)C(=C)c3ccc(Cn4ccccc4=O)cc3)c2c1

InChI Key InChIKey=NOZOSROFZDYHIK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 492884   

TargetPlasma kallikrein(Homo sapiens (Human))
Attune Pharmaceuticals

US Patent
LigandPNGBDBM492884(N-((5-chloro-1H- indazol-3-yl)methyl)-3- (1-(4-((2...)
Affinity DataIC50:  5.50E+3nMAssay Description:The ability of the compounds disclosed herein to inhibit human plasma kallikrein activity was quantified according to the procedures below.A 10 mM so...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent